Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: Prognostic significance of detection for early relapse

British Journal of Cancer

Volumn 104, Issue 7, 2011, Pages 1178-1184

  Lu, C Y ^a,b   Uen, Y H ^c,d   Tsai, H L ^e,f   Chuang, S C ^a,b   Hou, M F ^a,b   Wu, D C ^a,b   Hank Juo, S H ^b   Lin, S R ^f,g   Wang, J Y ^a,b,h,i  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^f FOOYIN UNIVERSITY   (Taiwan)

^g FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^h Division of General Surgery   (Taiwan)

ⁱ KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

circulating tumour cells; colon cancer; molecular detection; postoperative early relapse; UICC stage II III

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RELAPSE; CANCER STAGING; CIRCULATING TUMOR CELL; COLON CANCER; COLON RESECTION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD SPECIMEN COLLECTION; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KERATIN-19; KERATIN-20; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; POSTOPERATIVE PERIOD; PROGNOSIS; RNA, MESSENGER; TELOMERASE;

EID: 79953212868     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.40     Document Type: Article

References (34)

1. Allan AL, Keeney M (2010) Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010: 426218
2. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351 (Pubitemid 38702845)
3. Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J 14: 146-149
4. Bessa X, Elizalde JI, Boix L, Pinol V, Lacy AM, Salo J, Pique JM, Castells A (2001) Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120: 1084-1092 (Pubitemid 32246662)
5. Bessa X, Pinol V, Castellvi-Bel S, Piazuelo E, Lacy AM, Elizalde JI, Pique JM, Castells A (2003) Prognostic value of postoperative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure. Ann Surg 237: 368-375 (Pubitemid 38176452)
6. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti III A (2010) AJCC Cancer Staging Manual, 7th edn. Springer-Verlag: New York
7. Frederiksen BL, Jorgensen T, Brasso K, Holten I, Osler M (2010) Socioeconomic position and participation in colorectal cancer screening. Br J Cancer 103: 1496-1501
8. Gallagher DJ, Kemeny N (2010) Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78: 237-248
9. Greene FL (2006) Staging of colon and rectal cancer: from endoscopy to molecular markers. Surg Endosc 20(Suppl 2): S475-S478
10. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Muto T (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 141: 67-75 (Pubitemid 44918081)
11. Korner H, Soreide K, Stokkeland PJ, Soreide JA (2005) Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 9: 320-328 (Pubitemid 40327098)
12. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo D (2009a) Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27: 5131-5137
13. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009b) Perineural invasion in cancer: a review of the literature. Cancer 115: 3379-3391
14. Longo WE, Johnson FE (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82: 1091-1108 (Pubitemid 35463086)
15. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, Toouli J (1994) The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 37: 875-881 (Pubitemid 24281920)
16. Molnar B, Ladanyi A, Tanko L, Sreter L, Tulassay Z (2001) Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 7: 4080-4085 (Pubitemid 34044631)
17. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G (2009) Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 35: 201-209
18. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P (2010) Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review. Br J Cancer 102: 1327-1334
19. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, Diener MK, Buchler MW, Koch M, Weitz J (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138: 1714-1726
20. Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J, Pique JM, Castells A (2006) Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 24: 386-393 (Pubitemid 46630457)
21. Roukos DH, Murray S, Briasoulis E (2007) Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6: 308-312 (Pubitemid 47328293)
22. Steinert R, Hantschick M, Vieth M, Gastinger I, Kuhnel F, Lippert H, Reymond MA (2008) Influence of subclinical tumor spreading on survival after curative surgery for colorectal cancer. Arch Surg 143: 122-128 (Pubitemid 351281615)
23. Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY (2009) Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment. BMC Cancer 9: 288
24. Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, Chen CW, Wang JY (2009) Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 100: 736-743
25. Uen YH, Lu CY, Tsai HL, Yu FJ, Huang MY, Cheng TL, Lin SR, Wang JY (2008) Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Ann Surg Oncol 15: 2120-2128
26. Wang JY, Lin SR, Wu DC, Lu CY, Yu FJ, Hsieh JS, Cheng TL, Koay LB, Uen YH (2007) Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Cancer Res 13: 2406-2413
27. Wang JY, Yeh CS, Chen YF, Wu CH, Hsieh JS, Huang TJ, Huang SY, Lin SR (2006) Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Int J Mol Med 17: 737-747
28. Washington MK (2008) Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 132: 1600-1607
29. Wilkinson NW, Yothers G, Lopa S, Costantino JP, Petrelli NJ, Wolmark N (2010) Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol 17: 959-966
30. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW (2001) High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study. Dis Colon Rectum 44: 231-235 (Pubitemid 32173772)
31. Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT (2009) Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients. Clin Cancer Res 15: 1005-1012
32. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S (2000) Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232: 58-65 (Pubitemid 30456551)
33. Yeh CS, Wang JY, Wu CH, Chong IW, Chung FY, Wang YH, Yu YP, Lin SR (2006) Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Int J Oncol 28: 411-420
34. Zhang XW, Yang HY, Fan P, Yang L, Chen GY (2005) Detection of micrometastasis in peripheral blood by multi-sampling in patients with colorectal cancer. World J Gastroenterol 11: 436-438 (Pubitemid 40125259)